Propargyl-PEG3-acid | 1347760-82-0
Catalog Number | R02-0008 |
Category | Alkynes |
Molecular Formula | C10H16O5 |
Molecular Weight | 216.23 |
Catalog Number | Size | Price | Quantity |
---|---|---|---|
R02-0008 | -- | $-- |
- Worldwide Delivery
- Quality Assurance
- 24/7 Customer Service
Chemical Information |
|
---|---|
Synonyms | 3-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)propanoic acid; Propyne-PEG2-CH2CH2COOH; Alkyne-PEG3-COOH; Propargyl-PEG3-COOH; Propargyl-PEG3-Carboxylic Acid; 3-[2-[2-(2-Propyn-1-yloxy)ethoxy]ethoxy]propanoic acid; Propanoic acid, 3-[2-[2-(2-propyn-1-yloxy)ethoxy]ethoxy]- |
Purity | >98.0% |
Shelf Life | ≥ 2 years |
IUPAC Name | 3-[2-(2-prop-2-ynoxyethoxy)ethoxy]propanoic acid |
Canonical SMILES | C#CCOCCOCCOCCC(=O)O |
InChI | InChI=1S/C10H16O5/c1-2-4-13-6-8-15-9-7-14-5-3-10(11)12/h1H,3-9H2,(H,11,12) |
InChI Key | CJNSWLAJTZVSRB-UHFFFAOYSA-N |
Solubility | Soluble in DCM, DMF, DMSO, Water |
Density | 1.1±0.1 g/cm3 |
Appearance | Light yellow to brown clear liquid |
Boiling Point | 348.0±32.0 °C at 760 mmHg |
Vapor Pressure | 0.0±1.6 mmHg at 25°C |
LogP | -0.44 |
- Product Specification
Storage | Store at -20°C, keep in dry and avoid sunlight |
Signal | Warning |
GHS Hazard Statements | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] |
Precautionary Statement Codes | P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 |
Computed Properties | |
---|---|
XLogP3 | -0.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 216.09977361 g/mol |
Monoisotopic Mass | 216.09977361 g/mol |
Topological Polar Surface Area | 65Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 205 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
Patents
Publication Number | Title | Priority Date |
---|---|---|
TW-201800110-A | Antibody-drug conjugate based on eribulin and method of use | 2016-03-02 |
US-2017252458-A1 | Eribulin-based antibody-drug conjugates and methods of use | 2016-03-02 |
US-2018193478-A1 | Eribulin-based antibody-drug conjugates and methods of use | 2016-03-02 |
US-2017114341-A1 | Polynucleotide constructs having bioreversible and non-bioreversible groups | 2014-06-06 |
US-2020392498-A1 | Polynucleotide constructs having bioreversible and non-bioreversible groups | 2014-06-06 |
Applications of Fluorescent Probes & Dyes
Get More Product Details?
Related Products